4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-17-066693
President & CEO sold 104,131 shares at an average $1.15 ($119,325)
From the SEC's structured data for this filing
Trades in this filing
Mohan Pankaj · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-12-18 | Sale : show line 1 in the form | −20,523 | $1.17 | $24,012 | 7,254,838 | D |
| 2017-12-19 | Sale : show line 2 in the form | −83,608 | $1.14 | $95,313 | 7,171,230 | D |
| Open-market sales · 104,131 sh · avg $1.15 · $119,325 | ||||||
Loading xslF345X03/doc4.xml…